eMedicine Specialties > Dermatology > Environmental

Cutaneous Manifestations Following Exposures to Marine Life

Zoltan Trizna, MD, PhD, Private Practice

Updated: Feb 20, 2009

Introduction

Background

Exposure to aquatic life encompasses a variety of clinical situations. Dermatologists usually encounter patients with erythema, blisters, wheals, edema, scars, pigmentary changes, and paresthesias. Whereas the circumstances under which they occur and the distribution of these injuries can be characteristic, most of these lesions are not specific.

Cutaneous exposure to marine life occurs not only in the water but also when encountering living or dead marine animals on the beach. Commercial and recreational activities (eg, commercial or recreational fishing, beach combing, snorkeling, scuba diving, fish processing) have their specific concerns. Note that exposure to aquatic life can accompany various hobbies (eg, the keeping of saltwater fish tanks) or merchandising activities (eg, sellers of fish tank equipment of tropical fish).^1,2 Exposure to freshwater life can also cause cutaneous injuries, sometimes manifesting with skin lesions similar to those caused by saltwater life.

Treatment of the severe acute sequelae of exposure to hazardous marine animals (eg, cardiorespiratory arrest, anaphylactic shock, bleeding) is in the realm of emergency medicine. This article focuses only on the cutaneous sequelae of exposure to aquatic life. Some first-aid measures are briefly mentioned. For further details, see the eMedicine Emergency Medicine section, for example, the following articles:

• Conidae
• Cnidaria Envenomation
• Lionfish and Stonefish
• Octopus Envenomation
• Stingray Envenomation

Pathophysiology

The injuries can be grouped into several general categories. Overlap can also occur (such as when an abrasion also allows a toxin into injured skin or when microbes are inoculated into a puncture wound). Some of the injuries may be accompanied by bleeding and/or functional impairment of the affected area (eg, after extensive exposure to jellyfish tentacles). Others, such as injuries followed by the exposure to venoms, can be very mild and self-limited but may also lead to fatal consequences.

• Mechanical injuries without infection: Wounds are caused by punctures (eg, sea urchin spine), bites (eg, octopus or fish), cuts (eg, coral), suction (eg, octopus), abrasions, and lacerations (eg, shells). In rare instances, the human body can sustain a fatal injury to a vital organ, as documented by the case of "Crocodile Hunter" Steve Irwin. A strange case of a catfish sting causing fatal myocardial perforation was also documented.³
• Mechanical injuries followed by infection: Wounds become secondarily infected by either debris or microscopic organisms found in the water. Improper wound care (eg, rinsing injuries with seawater possibly loaded with microorganisms) can be a source of wound infections. Inoculation of infectious agents can commonly occur with penetration injuries or lacerations caused by sea urchin spine, stingray, seal bite,⁴ or other bites (eg, octopus, fish). Depending on the depth of the inoculation and on the microorganisms inoculated, severe infections of the underlying tissues and structures can also occur. In addition to possibly evolving into severe systemic infection, such processes may lead to deformities and loss of function.
• Mechanical injuries accompanied by the inoculation of a venom or a substance with sensitizing properties (eg, from sea anemone, sponges, scorpionfish, stonefish, lionfish, or stingray): The most commonly encountered phylum in this regard is the Cnidaria. These are animals that exhibit radial symmetry. Their body walls contain a jellylike substance. This phylum includes fire corals, hydroids, Portuguese man-of-war, jellyfish, sea anemones, and true corals.
  • Almost all of these possess nematocysts, frequently on a tentacle. The nematocysts contain a toxin that is injected into the skin. The sequelae of envenomations depend on the species involved, the nature and quantity of the toxin, and the size of the injured person.
  • Cutaneous reactions can be immediate (eg, wheals, vesicles, bullae, angioedema) or delayed hypersensitivity reactions. Complications include pain, postinflammatory hyperpigmentation, scarring, and contractions.
  • Systemic reactions range from mild to severe (eg, cardiac arrest, anaphylactic shock).
  • Two species of box jellyfish around Queensland (Australia) are known to produce venom with hemolytic, dermatonecrotic, and cardiotoxic components.
• Cutaneous exposure to a dead animal or its parts (including tentacles drifted to beaches): The lesions can be similar to those described in the above categories.
• Invasion of the skin by organisms: Cercarial dermatitis (ie, clam digger's itch, swimmer's itch) is caused by Schistosoma organisms penetrating the unprotected skin.
• Pyodermas and infections of the eyes, ears, or the urogenital tract: These can occur after bathing in contaminated water (eg, in areas where domestic or agricultural sewage mixes with water otherwise used for recreational activities), even in the absence of preceding mechanical injury. Existing wounds can become readily infected.⁵
• Mixed or hard-to-classify manifestations: These include, for example, granulomatous processes that may actually be caused by a microorganism (eg, Mycobacterium marinum genome identified in some granulomas).

Frequency

United States

Geographic area, season, and type of activity affect the prevalence of these injuries. With the increase of worldwide traveling, dermatologists may encounter lesions that would otherwise be unknown in their local area.

Mortality/Morbidity

Mortality or morbidity depends on the nature and severity of the injury. Infection with Vibrio vulnificus in an immunocompromised host can lead to septicemia and death. Morbidity observed in dermatologic practice includes infection, pigmentary changes, scarring, severe deformities, and loss of function.

Race

Persons of any race can be affected.

Sex

Both sexes can be affected.

Age

People of any age can be affected.

Clinical

History

• Patients can usually recall the circumstances of the encounter and the immediate sequelae.
• The encounter is usually noted because of either sudden trauma or an immediate stinging or burning pain. Dermatitis accompanied by local pain or systemic symptoms usually follows.
• Recent travels and recreational activities are relevant.
• Ask about preexisting wounds, which can provide a portal of entry for infections.
• Some professions may ignore the risk of such infections.

Physical

• Examine location and characteristics of the affected areas.
  • Certain contacts result in typical patterns and distribution (such as contact with tentacles resulting in characteristic linear eruptions on unprotected skin, seabather's eruption occurring on areas covered by clothing).
  • Stingray injuries commonly affect the unprotected skin of the legs.
  • Fingers are common areas for bites or injury when touching a life form that releases a toxin or inoculates microbes into the skin.
  • Tips of sea urchin spines can break off and become embedded in the wound.
• Carefully explore wounds.
  • Look for penetrating injuries, especially over joints.
  • Assess the wounded area for the presence of cellulitis, lymphangitis, pyogenic infections, cyanosis, and necrosis.
• Some bacterial infections are typically observed on certain sites.
  • Erysipeloid, caused by Erysipelothrix rhusiopathiae, typically affects the hands of anglers, although a diffuse cutaneous form has been described. Infection with this organism has been associated with septicemia and endocarditis.⁶
• Vibrio vulnificus infection usually manifests on the lower extremities as hemorrhagic bullae progressing to ulceration and necrosis. It may also cause life-threatening sepsis.
• M marinum infections may show sporotrichoid spread on the hand, wrist, and arm.
• Venoms have rarely been described to cause injuries to other organs, such as acute renal failure.⁷
• Delayed-type skin lesions such as erythema nodosum can occasionally be observed.⁸

Causes

• Bites and suction, where the injury is primarily mechanical, are caused by octopus, fish (eg, moray eel, barracuda, triggerfish), sharks, mammals (eg, sea lion, seal), and turtles.
• Cuts, abrasions, lacerations, and punctures can be caused by any part of the animal that is sharp or pointed, including sea urchins, starfish, stingray, coral, barnacles, broken shells, cone shell, spines of fish fins (eg, surgeonfish, needlefish), and leeches. Inanimate objects can also cause these types of injuries.
• Contact with toxic substances, including stings and other mechanical injuries resulting in the transfer of a venom, can occur after contact with fire coral, sea cucumber, bristleworm, sea anemone, sponges, stonefish, lionfish, scorpionfish, zebrafish, turkeyfish, catfish, jellyfish, Portuguese man-of-war, cone shell, starfish, and sea snakes (after bites).
• Mechanical injuries can result in wounds inoculated with microorganisms during the injury or in the course of wound care.
• Preexisting wounds can provide a readily available portal of entry for marine microorganisms (eg, V vulnificus) even in the absence of fresh trauma.
• Irritant dermatitis attributed to algae has been described in anglers working with nets.
• Delayed systemic sensitization has rarely been documented, manifesting as conjunctivitis, rhinitis, and asthma in anglers exposed to dragnets accidentally collecting red soft corals⁹ and in a case of an angler using a marine worm as fishing bait.¹⁰

Differential Diagnoses

Other Problems to Be Considered

Granuloma annulare¹¹

Workup

Laboratory Studies

• Culture and sensitivity of infected wounds
  • Consider cultures for atypical Mycobacteria (M marinum) in the presence of granulomatous and ulcerating lesions or sporotrichoid spread.
  • Other test results usually are noncontributory, unless systemic reactions are noted.
• Intracutaneous tests with species-specific extracts: These can detect immediate and delayed-type reactions.
• Serologic tests: These may reveal elevated immunoglobulins directed against specific antigens in patients with delayed cutaneous manifestations.

Imaging Studies

• Radiography is indicated to detect foreign body or involvement of deeper structures (eg, joint, bone).

Procedures

• Consider taking a biopsy when diagnosis is in doubt or when tissue culture is indicated.

Histologic Findings

Histologic findings generally are nonspecific.

In seabather's eruption, superficial and deep perivascular and interstitial infiltrate consisting of lymphocytes, neutrophils, and eosinophils are described.

Biopsy of tissues infected with M marinum shows a mixed suppurative and granulomatous reaction with sparse-to-absent acid-fast bacilli.

Delayed skin reaction can be characterized by liquefaction degeneration of the basal layer.

Polarized light can reveal symmetric structures, corresponding to cross-sections of sea urchin spines.

Infections with V vulnificus show a nonspecific, yet characteristic, picture. Destruction extends into the dermis without an inflammatory cell infiltrate. Vasculitis may be present. Subepidermal noninflammatory bullae can be noted. Multiple organisms are observed.

Treatment

Medical Care

Patients are usually seen in the dermatologist's office several hours or days after the initial injury. By the time of this encounter, the patient might already have undergone emergency treatment, including the use of specific measures such as the use of antivenins.

Evaluate the nature of the initial lesion and ask patients to describe any first aid measures that have been applied.

• If a foreign body is found or suspected, evaluate for deeper penetration. When in doubt, perform appropriate radiographic examinations. See Surgical Care for surgical evaluation. Remove the foreign body and close the wound if not infected. Consider using broad-spectrum oral antibiotics.
• In case of erythema, vesiculation, or blistering, instruct the patient regarding appropriate care. Prevent secondary infection by meticulous wound care and by protecting denuded areas. Topical corticosteroids are beneficial in combating the local reactions. Systemic steroids may be indicated in severe cases.
• Pain can be managed with analgetics selected according to severity of pain, pain tolerance of the patient, and other considerations (eg, age, presence of other medical problems).
• Scars or keloids causing disfigurement or functional limitations may be treated surgically.

Surgical Care

• First steps during acute care include controlling bleeding, cleaning the wound, removing visible foreign bodies (including sand), and covering with a (preferably sterile) dressing. Absorption of a toxin can be delayed by applying pressure over the wound and by placing elastic bandages approximately 15 cm (6 in) both distally and proximally of the wound. Check circulation periodically; arterial pulses should be detectable. In addition, immobilizing the patient or at least the affected area (eg, splinting the extremity, placing a sling) could help in delaying the absorption of the venom.
• Stings can be neutralized by irrigation with vinegar, baking soda (paste prepared with water), salt water, or papain powder or solution (meat tenderizer). Remove tentacles only after adequate neutralization. Remove sea urchin spines if possible. Submerse the affected area in hot water (up to 45°C or 113°F), scrub with water and soap, and irrigate copiously with fresh water. Remove deeply lodged spines after careful evaluation. Hot water immersion has also been suggested for nonpenetrating marine envenomations.¹²
• Nematocysts can discharge their contents on exposure to fresh water; therefore, irrigation of the exposed areas with fresh water is contraindicated. For the same reason, be sure that melting ice, applied for local pain control, cannot irrigate the wound site before neutralization.
• Assessing the need for further surgical care depends on the following:
  • Foreign bodies remaining in the wound and how deeply they may be lodged: Ideally, all foreign bodies should be removed because they can cause further toxin release, infection, granuloma formation, and functional limitations.
  • The presence of infection: In this case, obtain specimens for culturing. Initiate broad-spectrum antibiotic treatment and modify according to clinical response and culture results.
  • Cyanosis or necrosis: Determine the cause and initiate appropriate management.
  • Necessary debridement: Apply basic wound care measures as necessary.
  • Scarring: Any scarring that would be functionally limiting or cosmetically unacceptable. Consider treatment with intralesional steroid injections or surgical reconstruction.
  • Need for prosthetic replacement of a limb or its part: Subspecialty consultation may be appropriate.

Consultations

Consult specialists as required by the type of injury or complication (eg, orthopedic surgeon in case of joint or bone involvement, plastic surgeon in cases of extensive scars, infectious diseases specialist for complicated primary or secondary infections).

Activity

Activity is determined by the nature of the injury.

Medication

Medical therapy in the dermatologist's office includes topical treatment of hypersensitivity reactions, systemic corticosteroid treatment of severe hypersensitivity reactions, and topical or systemic antibiotics for the prevention or treatment of infections.

Treatment with antibiotics either is initiated empirically because culture and sensitivity results are not yet available or is tailored according to the laboratory results.

Generally, the use of a first-generation cephalosporin is appropriate for empirical therapy. For mycobacterial infections, rifampin, isoniazid, or ethambutol can be used, often in combination therapy. Some authors recommend sulfonamide alone or in combination with trimethoprim; others used minocycline, doxycycline, tetracycline, or cefoxitin. Culturing and sensitivity testing of the organisms in these situations is strongly advisable to initiate specific therapy. Antibiotic therapy of some infections (especially those caused by Mycobacteria) can be lengthy.^13,14

Corticosteroids

Used to alleviate local inflammation and accompanying pruritus or pain. Several topical steroids are available. Select the product according to the severity and location of the lesions (see Precautions in triamcinolone table). Triamcinolone is discussed only as a prototype.

Systemic steroids are used for the treatment of severe hypersensitivity reactions. They have anti-inflammatory effects and modify the immunologic responses. Exercise caution because of their metabolic effects. Prednisone is discussed as a prototype.

Triamcinolone (Aristocort)

Treats inflammatory dermatosis responsive to steroids. Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing capillary permeability.

Dosing

Adult

Apply a thin film bid/tid until a favorable response is obtained

Pediatric

Apply as in adults

Interactions

None reported

Contraindications

Documented hypersensitivity; fungal, viral, and bacterial skin infections

Precautions

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Prolonged use causes striae and atrophy; do not use in areas of decreased skin circulation; prolonged use, applications over large areas, and use of potent steroids and occlusive dressings may result in systemic absorption; systemic absorption may cause Cushing syndrome, reversible HPA axis suppression, hyperglycemia, and glycosuria

Prednisone (Deltasone)

Has anti-inflammatory properties. Must be metabolized to active metabolite prednisolone for effect, and thus, its conversion may be impaired in liver disease.

Dosing

Adult

40-80 mg qd or divided bid/qid; taper slowly over 4-6 wk as symptoms resolve to decrease chances of adverse reactions

Pediatric

0.5-1.5 mg/kg/d, qd, or divided bid/qid; taper over 4-6 wk, as symptoms resolve

Interactions

Coadministration with estrogens may decrease prednisone clearance; when used with digoxin, digitalis toxicity secondary to hypokalemia may increase; phenobarbital, phenytoin, and rifampin may increase metabolism of glucocorticoids (consider increasing maintenance dose); monitor for hypokalemia with coadministration of diuretics

Contraindications

Documented hypersensitivity; viral infection; peptic ulcer disease; hepatic dysfunction; connective tissue infections; hypertension; diabetes mellitus; fungal or tubercular skin infections; administration of vaccinations for immunization during treatment

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Exclude underlying infection before starting prednisone; monitor for hyperglycemia should long-term use be necessary; abrupt discontinuation may cause adrenal crisis; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections may occur

Antibiotics

For the prevention of infection (eg, patient experienced a penetrating injury, foreign body was inoculated into the wound) or for the treatment of a clinically apparent infection.

Initially, a broad-spectrum antibiotic should be selected. Penicillin G was once the drug of choice; however, it has fallen out of favor because of inactivity against penicillinase-producing bacteria, including many strains of staphylococci. Ideally, antibiotics should be selected after establishing the sensitivity of the microorganism.

For mycobacterial infections, the antibiotic treatment may be lengthy.

Ceftriaxone (Rocephin)

Third-generation cephalosporin with broad-spectrum gram-negative activity; lower efficacy against gram-positive organisms; higher efficacy against resistant organisms. Arrests bacterial growth by binding to one or more penicillin-binding proteins.

Dosing

Adult

Uncomplicated infections: 250 mg IM once
Severe infections: 1-2 g IV qd or divided bid; not to exceed 4 g/d

Pediatric

>7 days: 25-50 mg/kg/d IV/IM; not to exceed 125 mg/d
Infants and children: 50-75 mg/kg/d IV/IM divided q12h; not to exceed 2 g/d

Interactions

Probenecid may increase levels; coadministration with ethacrynic acid, furosemide, or aminoglycosides may increase nephrotoxicity; may increase risk of cyclosporine toxicity

Contraindications

Documented hypersensitivity; hyperbilirubinemic neonates; increased risk of bilirubin encephalopathy (kernicterus)

Precautions

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Adjust dose in severe renal insufficiency (high doses may cause CNS toxicity); superinfections and promotion of nonsusceptible organisms may occur with prolonged use or repeated therapy; caution in breastfeeding women

Rifampin (Rifadin, Rimactane)

Primarily for the treatment of tuberculosis. Inhibits DNA-dependent bacterial but not mammalian RNA polymerase. May be effective against aquatic M marinum. Additional medications can include co-trimoxazole, alone or combined with minocycline, clarithromycin, doxycycline, and ethambutol. Minocycline, doxycycline, or tetracycline as single agents have been used successfully to treat localized M marinum infections.

Dosing

Adult

10 mg/kg/d PO; not to exceed 600 mg qd as single dose

Pediatric

Administer as in adults

Interactions

Induces microsomal enzymes, which may decrease effects of acetaminophen, PO anticoagulants, barbiturates, benzodiazepines, beta-blockers, chloramphenicol, PO contraceptives, corticosteroids, mexiletine, cyclosporine, digitoxin, disopyramide, estrogens, hydantoins, methadone, clofibrate, quinidine, dapsone, tazobactam, sulfonylureas, theophyllines, tocainide, and digoxin; blood pressure may increase with coadministration of enalapril; coadministration with isoniazid may result in higher rate of hepatotoxicity than with either agent alone (discontinue one or both agents if alterations in LFTs occur)

Contraindications

Documented hypersensitivity

Precautions

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Obtain CBC counts and baseline clinical chemistries prior to and throughout therapy; in liver disease, weigh benefits against risk of further liver damage; interruption of therapy and high-dose intermittent therapy are associated with thrombocytopenia that is reversible if therapy is discontinued as soon as purpura occurs; if treatment is continued or resumed after appearance of purpura, cerebral hemorrhage or death may occur

Trimethoprim and sulfamethoxazole (Bactrim DS, Septra DS, Cotrim)

Inhibits bacterial growth by inhibiting synthesis of dihydrofolic acid. Antibacterial activity of TMP-SMZ includes common urinary tract pathogens, except Pseudomonas aeruginosa. Was found to be effective in some nontuberculotic mycobacterial infections.

Dosing

Adult

160 mg TMP/800 mg SMZ PO q12h for 10-14 d

Pediatric

<2 months: Do not administer
>2 months: 10-20 mg TMP/kg/d PO/IV divided tid/qid for 14 d

Interactions

May increase PT when used with warfarin (perform coagulation tests and adjust dose accordingly); coadministration with dapsone may increase blood levels of both drugs; coadministration of diuretics increases incidence of thrombocytopenia purpura in elderly patients; phenytoin levels may increase with coadministration; may potentiate effects of methotrexate in bone marrow depression; hypoglycemic response to sulfonylureas may increase with coadministration; may increase levels of zidovudine; coadministration of pyrimethamine with cotrimoxazole, an antifolic drug, may increase risk of bone marrow suppression; severe hyperkalemia has been reported with the concurrent use of ACE inhibitors and trimethoprim; cotrimoxazole and lamivudine may cause elevated lamivudine serum concentrations

Contraindications

Documented hypersensitivity; megaloblastic anemia due to folate deficiency; <2 mo of age; pregnant patients at term, nursing mothers

Precautions

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Discontinue at first appearance of skin rash or sign of adverse reaction, immune hypersensitivity reaction (severe), Stevens-Johnson syndrome, or toxic epidermal necrolysis; obtain CBC counts frequently; discontinue therapy if significant hematologic changes occur; goiter, diuresis, and hypoglycemia may occur with sulfonamides; prolonged IV infusions or high doses may cause bone marrow depression (if signs occur, administer 5-15 mg/d leucovorin); caution in folate deficiency (eg, people with long-term alcoholism, elderly people, those receiving anticonvulsant therapy, those with malabsorption syndrome); hemolysis may occur in people with G-6-PD deficiency; AIDS patients may not tolerate or respond to TMP-SMZ; caution in renal or hepatic impairment (perform urinalyses and renal function tests during therapy); administer fluids to prevent crystalluria and stone formation

Minocycline (Dynacin, Minocin)

Treats infections caused by susceptible gram-negative and gram-positive organisms, in addition to infections caused by susceptible Chlamydia, Rickettsia, and Mycoplasma. Was found to be effective in some nontuberculotic mycobacterial infections.

Dosing

Adult

100 mg PO bid for 5-7 d

Pediatric

<8 years: Not recommended
>8 years: 4 mg/kg PO initially, followed by 2 mg/kg q12h
Alternatively, 200 mg PO/IV initially

Interactions

Bioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; can decrease effects of PO contraceptives, causing breakthrough bleeding and increased risk of pregnancy; tetracyclines can increase hypoprothrombinemic effects of anticoagulants; concomitant use of vitamin A supplementation or oral retinoids (eg, isotretinoin) not recommended; additive risk of pseudotumor cerebri; simultaneous administration of cinnamon and tetracycline may slow tetracycline absorption; bacteriostatic drugs (eg, tetracyclines) may interfere with bactericidal effect of penicillin

Contraindications

Documented hypersensitivity; severe hepatic dysfunction

Precautions

Pregnancy

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Photosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines; hepatitis or lupuslike syndromes may occur; autoimmune syndromes; drug-induced lupus – like syndrome, hepatitis, and vasculitis reported with long-term use; caution in preexisting renal impairment; risk of azotemia, hyperphosphatemia, and acidosis due to drug accumulation; minocycline use may result in false elevations of urinary catecholamine levels due to interference with the fluorescence test

Follow-up

Further Inpatient Care

• Further inpatient care depends on the nature of the exposure or injury.

Further Outpatient Care

• Follow-up is determined by the nature of the injury.

Inpatient & Outpatient Medications

• Medications are prescribed as required by the underlying pathophysiology or complications.

Complications

• Most of the cutaneous sequelae of aqueous exposure resolve without severe long-term problems.
• Pigmentary changes and scarring may occur.
• Functional limitation and disfigurement may be observed, and these can be treated (see Surgical Care).
• Delayed-type reactions may require treatment.

Prognosis

• Limited local reactions usually resolve without serious sequelae. Otherwise, prognosis depends on the extent of local and systemic reactions, such as cardiovascular collapse, or functional impairment of the limbs or other structures.

Patient Education

• Prevention is important. Instruct patients to protect against re-exposure.
• Avoid touching marine animals, including beached organisms or animal parts (eg, broken jellyfish tentacles).
• Use protective equipment such as specially designed gloves when cleaning fish, shellfish, or invertebrates.
• Wear a wet suit while surfing, snorkeling, or diving.
• Avoid areas with known high risk of exposure such as shallow coral reefs where sea urchins can dwell.
• Other methods of avoiding marine life are specific to given geographic areas (eg, walking with a shuffle in shallow water where stingrays may be encountered) and to a particular commercial or recreational activity (eg, fish cleaning).
• For excellent patient education resources, visit eMedicine's Bites and Stings Center. Also, see eMedicine's patient education article
  Stingray Injury.

Miscellaneous

Medicolegal Pitfalls

• Misdiagnosis: Several potential pitfalls exist. These include not suspecting a foreign body remains in the wound, not diagnosing the systemic effects of the envenomation, and not performing a culture and sensitivity assay and thereby missing rare causes of bacterial infections.

Special Concerns

• Children and elderly patients may be extremely susceptible to exposure to venoms.
• Immunocompromised patients are more vulnerable to systemic infections and life-threatening sequelae.

Multimedia

Media file 1: Mycobacterium marinum infection. Courtesy of the Department of Dermatology, UTMB at Galveston, Texas.

Media file 2: Jellyfish stings. Courtesy of the Department of Dermatology, UTMB at Galveston, Texas.

Media file 3: Erysipeloid. Courtesy of the Department of Dermatology, UTMB at Galveston, Texas.

Media file 4: Envenomation caused by Portuguese-man-of-war. Courtesy of the Department of Dermatology, UTMB at Galveston, Texas.

References

1. Schmoor P, Descamps V, Bouscarat F, Grossin M, Belaich S, Crickx B. [Tropical fish salesmen's knowledge and behaviour concerning "fish tank granuloma"]. Ann Dermatol Venereol. Apr 2003;130(4):425-7. [Medline].

2. Tong DW. Skin hazards of the marine aquarium industry. Int J Dermatol. Mar 1996;35(3):153-8. [Medline].

3. Haddad V, de Souza RA, Auerbach PS. Marine catfish sting causing fatal heart perforation in a fisherman. Wilderness Environ Med. Summer 2008;19(2):114-8. [Medline].

4. Clark C, McIntyre PG, Evans A, McInnes CJ, Lewis-Jones S. Human sealpox resulting from a seal bite: confirmation that sealpox virus is zoonotic. Br J Dermatol. Apr 2005;152(4):791-3. [Medline].

5. Fleisher JM, Kay D, Salmon RL, Jones F, Wyer MD, Godfree AF. Marine waters contaminated with domestic sewage: nonenteric illnesses associated with bather exposure in the United Kingdom. Am J Public Health. Sep 1996;86(9):1228-34. [Medline].

6. Brooke CJ, Riley TV. Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. J Med Microbiol. Sep 1999;48(9):789-99. [Medline].

7. Mizuno M, Nishikawa K, Yuzawa Y, et al. Acute renal failure after a sea anemone sting. Am J Kidney Dis. Aug 2000;36(2):E10. [Medline].

8. Auerbach PS, Hays JT. Erythema nodosum following a jellyfish sting. J Emerg Med. Nov-Dec 1987;5(6):487-91. [Medline].

9. Onizuka R, Inoue K, Kamiya H. [Red soft coral-induced allergic symptoms observed in spiny lobster fishermen]. Arerugi. Mar 1990;39(3):339-47. [Medline].

10. Valero A, Huguet J, Sanosa J, Malet A, Garcia-Calderon PA. Dermato-respiratory allergy induced by a marine worm (Marphysa sanguinea) used as fishing bait. Ann Allergy. Jun 1989;62(6):514-7. [Medline].

11. Barr KL, Lowe L, Su LD. Mycobacterium marinum infection simulating interstitial granuloma annulare: a report of two cases. Am J Dermatopathol. Apr 2003;25(2):148-51. [Medline].

12. Atkinson PR, Boyle A, Hartin D, McAuley D. Is hot water immersion an effective treatment for marine envenomation?. Emerg Med J. Jul 2006;23(7):503-8. [Medline].

13. Cummins DL, Delacerda D, Tausk FA. Mycobacterium marinum with different responses to second-generation tetracyclines. Int J Dermatol. Jun 2005;44(6):518-20. [Medline].

14. Wallace RJ Jr, Wiss K, Bushby MB, Hollowell DC. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria. Rev Infect Dis. Mar-Apr 1982;4(2):326-31. [Medline].

15. Basler RS, Basler GC, Palmer AH, Garcia MA. Special skin symptoms seen in swimmers. J Am Acad Dermatol. Aug 2000;43(2 Pt 1):299-305. [Medline].

16. Borenstein M, Kerdel F. Infections with Vibrio vulnificus. Dermatol Clin. Apr 2003;21(2):245-8. [Medline].

17. Holmes JL. Marine stingers in far north Queensland. Australas J Dermatol. May 1996;37 Suppl 1:S23-6. [Medline].

18. Kumamoto KS, Vukich DJ. Clinical infections of Vibrio vulnificus: a case report and review of the literature. J Emerg Med. Jan-Feb 1998;16(1):61-6. [Medline].

19. Penman AD, Lanier DC Jr, Avara WT 3rd, et al. Vibrio vulnificus wound infections from the Mississippi Gulf coastal waters: June to August 1993. South Med J. May 1995;88(5):531-3. [Medline].

20. Street ML, Umbert-Millet IJ, Roberts GD, Su WP. Nontuberculous mycobacterial infections of the skin. Report of fourteen cases and review of the literature. J Am Acad Dermatol. Feb 1991;24(2 Pt 1):208-15. [Medline].

Keywords

marine envenomations, saltwater injury, marine creature injury, exposure to saltwater life, exposure to freshwater life

Contributor Information and Disclosures

Author

Zoltan Trizna, MD, PhD, Private Practice
Zoltan Trizna, MD, PhD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Medical Editor

James J Nordlund, MD, Professor Emeritus, Department of Dermatology, University of Cincinnati College of Medicine
James J Nordlund, MD is a member of the following medical societies: American Academy of Dermatology, Sigma Xi, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey Meffert, MD, Assistant Clinical Professor of Dermatology, University of Texas Health Science Center-San Antonio
Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, and Texas Dermatological Society
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System
William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology
Disclosure: elsevier Royalty Other; american college of physicians Honoraria Other

© 1994- by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)